Search

Your search keyword '"Hallberg B"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Hallberg B" Remove constraint Author: "Hallberg B" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
52 results on '"Hallberg B"'

Search Results

1. A “grappling hook” interaction connects self-assembly and chaperone activity of Nucleophosmin 1

2. Adherence to oxygen saturation targets increased in preterm infants when a higher target range and tighter alarm limits were introduced

Catalog

Books, media, physical & digital resources

3. Shaken baby syndrome and the risk of losing scientific scrutiny

4. Early-life hyperglycemia in extremely preterm infants affects neurodevelopment at 6 years of age

5. The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

6. Cohort study of growth patterns by gestational age in preterm infants developing morbidity

7. The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

8. Cohort study of growth patterns by gestational age in preterm infants developing morbidity

9. The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

10. Cohort study of growth patterns by gestational age in preterm infants developing morbidity

11. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib

15. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

16. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

17. The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

18. Cohort study of growth patterns by gestational age in preterm infants developing morbidity

19. Cohort study of growth patterns by gestational age in preterm infants developing morbidity

20. Cohort study of growth patterns by gestational age in preterm infants developing morbidity

21. The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

22. Structural basis for cellobiose dehydrogenase action during oxidative cellulose degradation

23. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

24. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

25. Common germline polymorphisms associated with breast cancer-specific survival

26. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

27. Bumetanide and Hearing Loss : Results of a Phase I/Ii Dose Finding and Feasibility Trial of Bumetanide for Second Line Treatment of Neonatal Seizures (Nemo)

28. PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations.

29. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

30. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

31. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

33. A physical-optics model for double-bounce scattering from tree stems standing on an undulating ground surface

34. Crystal structure of YegS, a homologue to the mammalian diacylglycerol kinases, reveals a novel regulatory metal binding site

35. Cellobiose dehydrogenase - A flavocytochrome from wood-degrading, phytopathogenic and saprotropic fungi

36. Structural basis for substrate binding and regioselective oxidation of monosaccharides at C3 by pyranose 2-oxidase

37. The closed structure of presequence protease PreP forms a unique 10,000 Angstroms3 chamber for proteolysis.

38. Catalytic mechanism of limonene epoxide hydrolase : a theoretical study

43. Mechanism of the reductive half-reaction in cellobiose dehydrogenase

44. The heme domain of cellobiose oxidoreductase : a one-electron reducing system

45. Biophysical and structural analysis of a novel heme b iron ligation in the flavocytochrome cellobiose dehydrogenase

46. Crystal structure of the flavoprotein domain of the extracellular flavocytochrome cellobiose dehydrogenase

47. Cellobiose quinone oxidoreductase from the white rot fungus Phanerochaete chrysosporium is produced by intracellular proteolysis of cellobiose dehydrogenase

48. Cellobiose Quinone Oxidoreductase from the white rot fungus Phanerochaete chrysosporium is produced by intracellular proteolysis of Cellobiose Dehydrogenase.

49. Production and characterization of recombinant Phanerochaete chrysosporium cellobiose dehydrogenase in the methylotrophic yeast Pichia pastoris

50. A new scaffold for binding haem in the cytochrome domain of the extracellular flavocytochrome cellobiose dehydrogenase